Capone, Stefania http://orcid.org/0000-0002-2272-120X
Brown, Anthony
Hartnell, Felicity
Sorbo, Mariarosaria Del
Traboni, Cinzia
Vassilev, Ventzislav
Colloca, Stefano
Nicosia, Alfredo
Cortese, Riccardo
Folgori, Antonella
Klenerman, Paul
Barnes, Eleanor
Swadling, Leo http://orcid.org/0000-0002-0537-6715
Funding for this research was provided by:
RCUK | MRC | Medical Research Foundation (MRF-044-0001-RG-SWADL)
Wellcome Trust
U.S. Department of Health & Human Services | NIH | Center for Scientific Review (2U19AI082630-06)
Article History
Received: 26 March 2020
Accepted: 20 August 2020
First Online: 12 October 2020
Competing interests
: S.Co., A.F., R.C., and A.N. are named inventors on patent applications covering HCV-vectored vaccines and chimpanzee adenovirus vectors [WO 2006133911 (A3) hepatitis C virus nucleic acid vaccine, WO 2005071093 (A3) chimpanzee adenovirus vaccine carriers, WO 03031588 (A2) hepatitis C virus vaccine]. V.V. is an employee of GSK group of companies. The rest of the authors declare that there are no competing interests.